- Home
- MNPR vs ESP Comparison
MNPR vs ESP Comparison
Compare MNPR & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- ESP
- Stock Information
- Founded
- MNPR 2014
- ESP 1928
- Country
- MNPR United States
- ESP United States
- Employees
- MNPR N/A
- ESP N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- ESP Industrial Machinery/Components
- Sector
- MNPR Health Care
- ESP Technology
- Exchange
- MNPR Nasdaq
- ESP Nasdaq
- Market Cap
- MNPR 390.5M
- ESP 148.8M
- IPO Year
- MNPR 2019
- ESP N/A
- Fundamental
- Price
- MNPR $79.90
- ESP $36.58
- Analyst Decision
- MNPR Strong Buy
- ESP
- Analyst Count
- MNPR 12
- ESP 0
- Target Price
- MNPR $96.64
- ESP N/A
- AVG Volume (30 Days)
- MNPR 86.5K
- ESP 33.6K
- Earning Date
- MNPR 11-07-2025
- ESP 11-12-2025
- Dividend Yield
- MNPR N/A
- ESP 2.69%
- EPS Growth
- MNPR N/A
- ESP 31.88
- EPS
- MNPR N/A
- ESP 3.02
- Revenue
- MNPR N/A
- ESP $43,950,872.00
- Revenue This Year
- MNPR N/A
- ESP N/A
- Revenue Next Year
- MNPR N/A
- ESP N/A
- P/E Ratio
- MNPR N/A
- ESP $12.75
- Revenue Growth
- MNPR N/A
- ESP 13.46
- 52 Week Low
- MNPR $4.50
- ESP $24.85
- 52 Week High
- MNPR $105.00
- ESP $55.00
- Technical
- Relative Strength Index (RSI)
- MNPR 50.09
- ESP 32.78
- Support Level
- MNPR $86.26
- ESP $36.03
- Resistance Level
- MNPR $104.00
- ESP $39.19
- Average True Range (ATR)
- MNPR 9.24
- ESP 1.57
- MACD
- MNPR -2.96
- ESP 0.02
- Stochastic Oscillator
- MNPR 20.25
- ESP 15.37
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.